A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

By Aron A.R.   Dowson J.H.   Sahakian B.J.   Robbins T.W.  

Biological Psychiatry, Vol. 54, Iss. 12, 2003-12 ,pp. : 1465-1468

Elsevier

Access to resources Recommend Favorite

Beyond the 'typical' patient: Treating attention-deficit/hyperactivity disorder in preschoolers and adults

By Vaughan Brigette   Wetzel Martin   Kratochvil Christopher  

International Review of Psychiatry, Vol. 20, Iss. 2, 2008-04 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite

Brain iron levels in attention-deficit/hyperactivity disorder: A pilot MRI study

By Cortese Samuele  

World Journal of Biological Psychiatry, Vol. 13, Iss. 3, 2012-03 ,pp. : 223-231

Informa Healthcare

Access to resources Recommend Favorite

Heart Rate Variability in Children with Attention-Deficit/Hyperactivity Disorder: A Pilot Study

By  

Annals of Neurosciences, Vol. 23, Iss. 2, 2016-07 ,pp. : 81-88

Karger

Access to resources Recommend Favorite